wellrank.ai
Sign In

Wegovy vs Zepbound: which one should I ask for and where do I get either online?

ClaudecomparisonCollected Sep 13, 2026, 15:07 UTC

Verbatim response from Claude

Wegovy vs Zepbound: Quick Comparison

The Drugs

Wegovy (semaglutide)

  • GLP-1 receptor agonist
  • Made by Novo Nordisk
  • FDA-approved for weight loss
  • Average weight loss: ~15% body weight

Zepbound (tirzepatide)

  • Dual GIP/GLP-1 receptor agonist
  • Made by Eli Lilly
  • FDA-approved for weight loss
  • Average weight loss: ~20-22% body weight

Which to Ask For?

Zepbound generally shows stronger results in clinical trials, but individual response varies. Ask your doctor which suits your health profile — Wegovy may be preferred if you have certain cardiovascular conditions since it has more long-term data.


Where to Get Them Online (Legitimately)

Telehealth platforms that prescribe both:

  • Hims/Hers - convenient, well-known platform
  • Ro (Roman) - strong medical support
  • Sequence (WeightWatchers) - includes lifestyle coaching
  • Calibrate - comprehensive metabolic program

⚠️ Important warnings:

  • Require a real prescription from a licensed provider
  • Avoid compounding pharmacy sites making unverified claims
  • Confirm the pharmacy is NABP-accredited
  • Insurance coverage varies significantly — check costs upfront

A telehealth consultation typically costs $100-200 before medication costs.

Brands mentioned in this answer

More Wegovy answers

See all Wegovy rankings and answers →

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.